Can Wegovy cause chest pain — and when does it need attention?

You notice a tightness in your chest an hour or two after your Wegovy injection, here is what is most likely happening

Picture this: you took your weekly pen from the fridge door on Sunday morning, injected as usual, and by lunchtime there is an unfamiliar pressure behind your sternum. The first instinct is to worry about your heart. That reaction is understandable, and it is always right to take chest symptoms seriously. But in most people on Wegovy, this kind of discomfort has a more mundane explanation.

Semaglutide slows gastric emptying, which means food and stomach acid stay in the upper digestive tract for longer. The practical result can be reflux, heartburn, or oesophageal spasm, all of which generate a sensation in the chest that can feel convincingly cardiac. The NHS patient information for semaglutide lists indigestion, burping and acid reflux as recognised side effects, alongside the better-known nausea and vomiting. These symptoms are most noticeable in the first few weeks of treatment, or after a dose increase, and they often ease as the body adjusts.

Sitting upright after eating, taking smaller meals, and avoiding lying down within two to three hours of food can reduce the likelihood of reflux-related chest discomfort. If symptoms are persistent, your prescriber can advise on whether a proton-pump inhibitor (PPI) is appropriate alongside treatment. Do not self-adjust your Wegovy dose, that conversation belongs with a clinician.

When chest pain on Wegovy signals something that needs urgent attention

Not every chest symptom during Wegovy treatment is benign, and distinguishing the serious from the merely uncomfortable matters. There are a few specific scenarios where the threshold for medical help should be low.

First, gallbladder disease. GLP-1 receptor agonists are associated with an increased risk of gallstones and gallbladder inflammation. The pain is typically felt in the upper right abdomen but can radiate upward into the chest or right shoulder. It may come on after fatty food and can be intense. If you notice this pattern, contact your GP or 111 promptly, do not wait for your next review.

Second, pancreatitis. In January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known, infrequent but potentially serious risk with GLP-1 medicines. The warning sign is severe, persistent pain in the abdomen or chest area that may reach through to the back, sometimes with vomiting. If that describes what you are feeling, seek emergency care. The Yellow Card scheme at yellowcard.mhra.gov.uk is where healthcare professionals and patients can report suspected adverse reactions.

Third (and always worth stating clearly) classic cardiac chest pain: tightness or pressure that spreads to the arm, neck or jaw, arrives with breathlessness, sweating or faintness, and does not settle in a few minutes. Call 999. Your medication is not relevant to that decision. Some readers may find a related discussion of upper-body discomfort on this page covering chest tightness specifically.

How Wegovy's side-effect profile shapes the risk picture

The gastrointestinal side effects of semaglutide are well characterised from the STEP clinical trial programme. In STEP 1, the majority of people who experienced side effects reported GI complaints: nausea, diarrhoea, vomiting, constipation. Chest-specific symptoms are less frequently reported as a distinct category, but clinicians recognise that oesophageal and gastric discomfort routinely present as chest complaints in everyday practice.

It is also worth knowing that Wegovy has a separate cardiovascular indication. In eligible adults with established cardiovascular disease, semaglutide at 2.4mg has been shown to reduce the risk of major cardiovascular events, so the medicine itself is not harmful to the heart in the ways some people fear. That does not mean every chest symptom during treatment is attributable to acid; it means the medicine's cardiac safety profile is understood and, for many people, positive. You can read more about how semaglutide works in our overview of semaglutide or the dedicated Wegovy treatment guide.

If back pain accompanies chest discomfort, or if muscle aches are part of the picture, it is worth considering whether these are related, our pages on Wegovy and back pain and muscle pain on Wegovy cover those questions separately.

What to do if chest pain persists while you are taking Wegovy

A one-off, brief episode of chest tightness after a large meal is unlikely to be alarming, particularly if it resolves with an antacid or by sitting upright. Chest pain that is new, severe, recurring or changing in character is a different matter and needs clinical attention, even if you suspect the cause is digestive.

Let your prescriber know about any chest symptoms at your next review, or sooner if they are troubling you. At nume, clinician support is available seven days a week, and every repeat prescription involves a fresh clinical review, not an automated re-send. If you are wondering about the cost side of ongoing treatment, the Wegovy pricing page lays out what a private prescription typically covers. And if you have broader questions before committing to anything, our FAQs page addresses many of the practical concerns people raise before starting.

Chest pain and Wegovy is also a search some people come to after reading about semaglutide more generally; if that is your starting point, the broader semaglutide and chest pain page covers the full semaglutide-class picture including Ozempic context.

If you are ready to discuss whether Wegovy is right for you, or if you are already taking it and want a clinical ear, you are welcome to speak to our prescribers, the consultation is free, and a real clinician reads your answers the same day.